Search Results - "van Rossum, N"

Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study by Rakauskas, Arnas, Peters, Max, Martel, Paul, van Rossum, Peter S N, La Rosa, Stefano, Meuwly, Jean-Yves, Roth, Beat, Valerio, Massimo

“…High-resolution micro-ultrasound (micro-US) is a novel precise imaging modality that allows targeted prostate biopsies and multiparametric magnet resonance…”
Get full text

Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands by Visser, Els, Rossum, Peter S. N van, Ruurda, Jelle P, Hillegersberg, Richard van

“…OBJECTIVE:To evaluate the impact of lymph node yield (LNY) on survival in patients treated with neoadjuvant chemoradiotherapy (nCRT) followed by esophagectomy…”
Get full text

Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent by Parry, K., Visser, E., van Rossum, P. S. N., Mohammad, N. Haj, Ruurda, J. P., van Hillegersberg, R.

“…Background Strategies for the treatment of recurrence after initial curative esophagectomy are increasingly being recognized. The aim of this study was to…”
Get full text

A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol by Palma, David A, Giuliani, Meredith E, Correa, Rohann J M, Schneiders, Famke L, Harrow, Stephen, Guckenberger, Matthias, Zhang, Tina, Bahig, Houda, Senthi, Sashendra, Chung, Peter, Olson, Robert, Lock, Michael, Raman, Srinivas, Bauman, Glenn S, Lok, Benjamin H, Laba, Joanna M, Glicksman, Rachel M, Nguyen, Timothy K, Lang, Pencilla, Helou, Joelle, Goodman, Christopher D, Mendez, Lucas C, van Rossum, Peter S N, Warner, Andrew, Gaede, Stewart, Allan, Alison L

“…Emerging randomized data, mostly from phase II trials, have suggested that patients with oligometastatic cancers may benefit from ablative treatments such as…”
Get full text

Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer by Borggreve, Alicia S., Heethuis, Sophie E., Boekhoff, Mick R., Goense, Lucas, van Rossum, Peter S. N., Brosens, Lodewijk A. A., van Lier, Astrid L. H. M. W., van Hillegersberg, Richard, Lagendijk, Jan J. W., Mook, Stella, Ruurda, Jelle P., Meijer, Gert J.

“…Objective This study was conducted in order to determine the optimal timing of diffusion-weighted magnetic resonance imaging (DW-MRI) for prediction of…”
Get full text

Adding PD-1 inhibition to chemoradiotherapy for oesophageal cancer by van Laarhoven, Hanneke W M, van Rossum, Peter S N

Get full text

Editorial: Updates on radiation-induced lymphopenia by Damen, Pim J J, Lin, Steven H, van Rossum, Peter S N

Get full text

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma by Goense, Lucas, van Rossum, Peter S. N., Xi, Mian, Maru, Dipen M., Carter, Brett W., Meijer, Gert J., Ho, Linus, van Hillegersberg, Richard, Hofstetter, Wayne L., Lin, Steven H.

“…Purpose To develop a nomogram that estimates 1-year recurrence-free survival (RFS) after trimodality therapy for esophageal adenocarcinoma and to assess the…”
Get full text

Letter to the Editor on the article “The role of low CRP values in the prediction of the development of acute diverticulitis” by Kechagias, Aristotelis, van Rossum, Peter S. N.

Get full text

Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends by van Rossum, Peter S. N., Mohammad, Nadia Haj, Vleggaar, Frank P., van Hillegersberg, Richard

“…Key Points In patients with unresectable or metastatic oesophageal carcinoma, the best possible outcomes are achieved through an individualized approach by a…”
Get full text

Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models by van Rossum, Peter S. N., Juan-Cruz, Celia, Stam, Barbara, Rossi, Maddalena M. G., Lin, Steven H., Abravan, Azadeh, Belderbos, José S. A., Sonke, Jan-Jakob

“…Background Severe radiation-induced lymphopenia (RIL) in patients undergoing chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC) is associated with…”
Get full text

Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score‐matched analysis comparing toxicity, pathologic outcome, and survival by Goense, Lucas, van der Sluis, Pieter C., van Rossum, Peter S. N., van der Horst, Sylvia, Meijer, Gert J., Haj Mohammad, Nadia, van Vulpen, Marco, Mook, Stella, Ruurda, Jelle P., van Hillegersberg, Richard

“…Objectives To evaluate toxicity, pathologic outcome, and survival after perioperative chemotherapy (pCT) compared to neoadjuvant chemoradiotherapy (nCRT)…”
Get full text

Elevated Electron Temperature Coincident with Observed Fusion Reactions in a Sheared-Flow-Stabilized Z Pinch by Levitt, B, Goyon, C, Banasek, J T, Bott-Suzuki, S C, Liekhus-Schmaltz, C, Meier, E T, Morton, L A, Taylor, A, Young, W C, Nelson, B A, Sutherland, D A, Quinley, M, Stepanov, A D, Barhydt, J R, Tsai, P, Morgan, K D, van Rossum, N, Hossack, A C, Weber, T R, McGehee, W A, Nguyen, P, Shah, A, Kiddy, S, Van Patten, M, Youmans, A E, Higginson, D P, McLean, H S, Wurden, G A, Shumlak, U

“…The sheared-flow-stabilized Z pinch concept has been studied extensively and is able to produce fusion-relevant plasma parameters along with neutron production…”
Get full text

ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer by Kroese, Tiuri E., van Rossum, Peter S. N., van Hillegersberg, Richard

Get full text

The peri‐esophageal connective tissue layers and related compartments: visualization by histology and magnetic resonance imaging by Weijs, T. J., Goense, L., Rossum, P. S. N., Meijer, G. J., Lier, A. L. H. M. W., Wessels, F. J., Braat, M. N. G., Lips, I. M., Ruurda, J. P., Cuesta, M. A., Hillegersberg, R., Bleys, R. L. A. W.

“…An organized layer of connective tissue coursing from aorta to esophagus was recently discovered in the mediastinum. The relations with other peri‐esophageal…”
Get full text

Cervical ultrasonography has no additional value over negative 18F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer by Goense, Lucas, Meziani, Jihane, van Rossum, Peter S. N., Wessels, Frank J., Lam, Marnix G. E. H., van Hillegersberg, Richard, Ruurda, Jelle P.

“…Objectives To investigate the additional value of cervical ultrasonography over 18 F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with…”
Get full text

Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis by Kroese, Tiuri E., van Laarhoven, Hanneke W.M., Nilsson, Magnus, Lordick, Florian, Guckenberger, Matthias, Ruurda, Jelle P., D'Ugo, Domenico, Haustermans, Karin, van Cutsem, Eric, van Hillegersberg, Richard, van Rossum, Peter S.N.

“…Local treatment (metastasectomy or stereotactic radiotherapy) for oligometastatic disease (OMD) in patients with esophagogastric cancer may improve overall…”
Get full text

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer by Kroese, Tiuri E., Buijs, George S., Burger, Matthijs D. L., Ruurda, Jelle P., Mook, Stella, Brosens, Lodewijk A. A., van Rossum, Peter S. N., van Hillegersberg, Richard

“…Background The primary goal of this study was to determine overall survival (OS) in patients who underwent local treatment (metastasectomy or stereotactic body…”
Get full text

The value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma by van Rossum, Peter S. N., Fried, David V., Zhang, Lifei, Hofstetter, Wayne L., Ho, Linus, Meijer, Gert J., Carter, Brett W., Court, Laurence E., Lin, Steven H.

“…Purpose The purpose of our study was to determine the value of 18 F-FDG PET before and after induction chemotherapy in patients with oesophageal adenocarcinoma…”
Get full text

Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands by Brenkman, H. J. F., Visser, E., van Rossum, P. S. N., Siesling, S., van Hillegersberg, R., Ruurda, J. P.

“…Background In the Netherlands, a maximum waiting time from diagnosis to treatment (WT) of 5 weeks is recommended for curative cancer treatment. This study…”
Get full text